Conroy Kevin T
Insider CIK 1306119 · ALGN Director · EXAS President and CEO, Director · ADPT Director · EPZM Director · ARYA Director · ABT Director · SLGCW Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ABT ABBOTT LABORATORIES | A Award deriv | 2026-09-30 | 2026-10-02 | 318 | $98.83 | $31.4K | 551 | SEC↗ |
| ABT ABBOTT LABORATORIES | F Tax w/h | 2026-09-23 | 2026-09-25 | 52,507 | $103.99 | $5.46M | 81,230 | SEC↗ |
| ABT ABBOTT LABORATORIES | F Tax w/h | 2026-09-23 | 2026-09-25 | 52,507 | $103.99 | $5.46M | 81,230 | SEC↗ |
| ABT ABBOTT LABORATORIES | A Award deriv | 2026-06-30 | 2026-07-01 | 231 | $90.74 | $21.0K | 231 | SEC↗ |
| ALGN ALIGN TECHNOLOGY INC | M Exercise deriv | 2026-05-20 | 2026-05-22 | 1,745 | — | $0 | 0 | SEC↗ |
| ALGN ALIGN TECHNOLOGY INC | A Award deriv | 2026-05-20 | 2026-05-22 | 1,836 | — | $0 | 1,836 | SEC↗ |
| ALGN ALIGN TECHNOLOGY INC | M Exercise | 2026-05-20 | 2026-05-22 | 1,745 | — | $0 | 3,553 | SEC↗ |
| ABT ABBOTT LABORATORIES | A Award | 2026-04-24 | 2026-04-28 | 2,286 | — | $0 | 133,737 | SEC↗ |
| EXAS EXACT SCIENCES CORP | D To issuer deriv | 2026-03-23 | 2026-03-23 | 235,388 | — | $0 | 0 | SEC↗ |
| EXAS EXACT SCIENCES CORP | D To issuer deriv | 2026-03-23 | 2026-03-23 | 66,047 | — | $0 | 0 | SEC↗ |
| EXAS EXACT SCIENCES CORP | D To issuer deriv | 2026-03-23 | 2026-03-23 | 34,110 | — | $0 | 0 | SEC↗ |
| EXAS EXACT SCIENCES CORP | D To issuer deriv | 2026-03-23 | 2026-03-23 | 100,916 | — | $0 | 0 | SEC↗ |
| EXAS EXACT SCIENCES CORP | D To issuer deriv | 2026-03-23 | 2026-03-23 | 83,360 | — | $0 | 0 | SEC↗ |
| EXAS EXACT SCIENCES CORP | D To issuer deriv | 2026-03-23 | 2026-03-23 | 44,336 | — | $0 | 0 | SEC↗ |
| EXAS EXACT SCIENCES CORP | D To issuer deriv | 2026-03-23 | 2026-03-23 | 18,143 | — | $0 | 0 | SEC↗ |
| EXAS EXACT SCIENCES CORP | D To issuer deriv | 2026-03-23 | 2026-03-23 | 154,829 | — | $0 | 0 | SEC↗ |
| EXAS EXACT SCIENCES CORP | D To issuer | 2026-03-23 | 2026-03-23 | 117,427 | — | $0 | 0 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award | 2026-03-23 | 2026-03-23 | 119,312 | — | $0 | 1,397,738 | SEC↗ |
| EXAS EXACT SCIENCES CORP | D To issuer | 2026-03-23 | 2026-03-23 | 1,397,738 | — | $0 | 0 | SEC↗ |
| EXAS EXACT SCIENCES CORP | D To issuer | 2026-03-23 | 2026-03-23 | 46,538 | — | $0 | 0 | SEC↗ |
| EXAS EXACT SCIENCES CORP | D To issuer | 2026-03-23 | 2026-03-23 | 86,750 | — | $0 | 0 | SEC↗ |
| EXAS EXACT SCIENCES CORP | D To issuer | 2026-03-23 | 2026-03-23 | 29,061 | — | $0 | 0 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2026-02-27 | 2026-03-03 | 18,143 | — | $0 | 18,143 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2026-02-27 | 2026-03-03 | 22,168 | — | $0 | 44,336 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2026-02-27 | 2026-03-03 | 27,786 | — | $0 | 83,360 | SEC↗ |
| EXAS EXACT SCIENCES CORP | F Tax w/h | 2026-02-27 | 2026-03-03 | 13,060 | $103.25 | $1.35M | 1,278,045 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2026-02-27 | 2026-03-03 | 18,143 | — | $0 | 1,260,098 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2026-02-27 | 2026-03-03 | 27,786 | — | $0 | 1,291,105 | SEC↗ |
| EXAS EXACT SCIENCES CORP | F Tax w/h | 2026-02-27 | 2026-03-03 | 10,419 | $103.25 | $1.08M | 1,263,319 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2026-02-27 | 2026-03-03 | 22,168 | — | $0 | 1,273,738 | SEC↗ |
| EXAS EXACT SCIENCES CORP | F Tax w/h | 2026-02-27 | 2026-03-03 | 8,528 | $103.25 | $880.5K | 1,251,570 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award deriv | 2026-02-25 | 2026-02-27 | 154,829 | — | $0 | 154,829 | SEC↗ |
| EXAS EXACT SCIENCES CORP | F Tax w/h | 2026-02-25 | 2026-02-27 | 6,196 | $103.45 | $641.0K | 1,241,955 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award | 2026-02-25 | 2026-02-27 | 13,181 | — | $0 | 1,248,151 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award | 2025-12-23 | 2025-12-30 | 244,931 | — | $0 | 1,101,519 | SEC↗ |
| EXAS EXACT SCIENCES CORP | F Tax w/h | 2025-12-23 | 2025-12-30 | 115,118 | $101.82 | $11.72M | 986,401 | SEC↗ |
| EXAS EXACT SCIENCES CORP | F Tax w/h | 2025-12-23 | 2025-12-30 | 65,014 | $101.82 | $6.62M | 1,059,713 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award | 2025-12-23 | 2025-12-30 | 138,326 | — | $0 | 1,124,727 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award | 2025-12-23 | 2025-12-30 | 330,674 | — | $0 | 155,417 | SEC↗ |
| EXAS EXACT SCIENCES CORP | F Tax w/h | 2025-12-23 | 2025-12-30 | 155,417 | $101.82 | $15.82M | 1,234,970 | SEC↗ |
| ALGN ALIGN TECHNOLOGY INC | A Award deriv | 2025-05-21 | 2025-05-22 | 1,745 | — | $0 | 1,745 | SEC↗ |
| ALGN ALIGN TECHNOLOGY INC | M Exercise deriv | 2025-05-21 | 2025-05-22 | 1,148 | — | $0 | 0 | SEC↗ |
| ALGN ALIGN TECHNOLOGY INC | M Exercise | 2025-05-21 | 2025-05-22 | 1,148 | — | $0 | 1,808 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2025-03-07 | 2025-03-10 | 66,723 | — | $0 | 0 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2025-03-07 | 2025-03-10 | 66,723 | $22.38 | $1.49M | 1,203,269 | SEC↗ |
| EXAS EXACT SCIENCES CORP | F Tax w/h | 2025-03-07 | 2025-03-10 | 48,929 | $47.06 | $2.30M | 1,154,340 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2025-02-28 | 2025-03-04 | 22,167 | — | $0 | 66,504 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2025-02-28 | 2025-03-04 | 18,143 | — | $0 | 36,286 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2025-02-28 | 2025-03-04 | 18,143 | — | $0 | 1,133,326 | SEC↗ |
| EXAS EXACT SCIENCES CORP | F Tax w/h | 2025-02-28 | 2025-03-04 | 8,528 | $47.82 | $407.8K | 1,124,798 | SEC↗ |
| EXAS EXACT SCIENCES CORP | F Tax w/h | 2025-02-28 | 2025-03-04 | 10,419 | $47.82 | $498.2K | 1,136,546 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2025-02-28 | 2025-03-04 | 22,167 | — | $0 | 1,146,965 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2025-02-25 | 2025-02-26 | 13,180 | — | $0 | 13,181 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2025-02-25 | 2025-02-26 | 13,180 | — | $0 | 1,121,378 | SEC↗ |
| EXAS EXACT SCIENCES CORP | F Tax w/h | 2025-02-25 | 2025-02-26 | 6,195 | $51.28 | $317.7K | 1,115,183 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award deriv | 2025-02-24 | 2025-02-26 | 111,146 | — | $0 | 111,146 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award | 2025-02-20 | 2025-02-21 | 48,044 | — | $0 | 1,129,338 | SEC↗ |
| EXAS EXACT SCIENCES CORP | F Tax w/h | 2025-02-20 | 2025-02-21 | 21,140 | $50.48 | $1.07M | 1,108,198 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2025-02-19 | 2025-02-21 | 10,374 | — | $0 | 0 | SEC↗ |
| EXAS EXACT SCIENCES CORP | F Tax w/h | 2025-02-19 | 2025-02-21 | 3,271 | $49.63 | $162.3K | 1,081,294 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2025-02-19 | 2025-02-21 | 10,374 | — | $0 | 1,084,565 | SEC↗ |
| EXAS EXACT SCIENCES CORP | P Buy | 2024-11-13 | 2024-11-13 | 19,500 | $51.35 | $1.00M | 1,074,191 | SEC↗ |
| ALGN ALIGN TECHNOLOGY INC | M Exercise deriv | 2024-05-22 | 2024-05-24 | 660 | — | $0 | 0 | SEC↗ |
| ALGN ALIGN TECHNOLOGY INC | A Award deriv | 2024-05-22 | 2024-05-24 | 1,148 | — | $0 | 1,148 | SEC↗ |
| ALGN ALIGN TECHNOLOGY INC | M Exercise | 2024-05-22 | 2024-05-24 | 660 | — | $0 | 660 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2024-05-01 | 2024-05-02 | 1,155 | $60.15 | $69.5K | 1,156,191 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award | 2024-04-30 | 2024-05-02 | 2,489 | — | $0 | 1,156,638 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award | 2024-04-30 | 2024-05-02 | 708 | $30.02 | $21.3K | 1,157,346 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2024-03-01 | 2024-03-04 | 8,271 | $59.32 | $490.6K | 1,299,496 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2024-02-29 | 2024-03-04 | 18,143 | — | $0 | 54,429 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2024-02-29 | 2024-03-04 | 18,143 | — | $0 | 1,307,767 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2024-02-27 | 2024-02-28 | 6,263 | $56.89 | $356.3K | 1,289,624 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award deriv | 2024-02-26 | 2024-02-28 | 88,671 | — | $0 | 88,671 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2024-02-26 | 2024-02-28 | 13,181 | — | $0 | 26,361 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2024-02-26 | 2024-02-28 | 13,181 | — | $0 | 1,295,887 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2024-02-23 | 2024-02-26 | 102,837 | — | $0 | 0 | SEC↗ |
| EXAS EXACT SCIENCES CORP | F Tax w/h | 2024-02-23 | 2024-02-26 | 61,560 | $57.53 | $3.54M | 1,282,706 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2024-02-23 | 2024-02-26 | 102,837 | $13.96 | $1.44M | 1,344,266 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2024-02-22 | 2024-02-23 | 11,565 | $59.78 | $691.4K | 1,241,429 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2024-02-21 | 2024-02-22 | 4,975 | $61.50 | $306.0K | 1,229,756 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award | 2024-02-21 | 2024-02-23 | 23,238 | — | $0 | 1,252,994 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2024-02-20 | 2024-02-22 | 10,374 | — | $0 | 0 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2024-02-20 | 2024-02-22 | 10,374 | — | $0 | 1,234,731 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2024-02-15 | 2024-02-16 | 14,791 | $61.43 | $908.6K | 1,224,357 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2024-02-14 | 2024-02-16 | 31,133 | — | $0 | 0 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2024-02-14 | 2024-02-16 | 31,133 | — | $0 | 1,239,148 | SEC↗ |
| ALGN ALIGN TECHNOLOGY INC | A Award deriv | 2023-12-05 | 2023-12-07 | 660 | — | $0 | 660 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award | 2023-05-01 | 2024-02-16 | 709 | $30.02 | $21.3K | 1,208,015 | SEC↗ |
| ADPT Adaptive Biotechnologies C | A Award deriv | 2023-03-06 | 2023-03-08 | 23,329 | — | $0 | 23,329 | SEC↗ |
| ADPT Adaptive Biotechnologies C | A Award | 2023-03-06 | 2023-03-08 | 14,775 | — | $0 | 22,968 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2023-02-28 | 2023-03-01 | 10,416 | $61.12 | $636.6K | 1,207,306 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2023-02-27 | 2023-03-01 | 13,180 | — | $0 | 39,541 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2023-02-27 | 2023-03-01 | 9,312 | — | $0 | 0 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2023-02-27 | 2023-03-01 | 9,312 | — | $0 | 1,217,722 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2023-02-27 | 2023-03-01 | 13,180 | — | $0 | 1,208,410 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award deriv | 2023-02-24 | 2023-02-28 | 72,572 | — | $0 | 72,572 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2023-02-22 | 2023-02-23 | 4,764 | $62.72 | $298.8K | 1,195,230 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2023-02-21 | 2023-02-23 | 10,374 | — | $0 | 20,747 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2023-02-21 | 2023-02-23 | 10,374 | — | $0 | 1,199,994 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2023-02-15 | 2023-02-16 | 14,617 | $65.59 | $958.7K | 1,189,620 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2023-02-14 | 2023-02-16 | 31,132 | — | $0 | 31,132 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2023-02-14 | 2023-02-16 | 31,132 | — | $0 | 1,204,237 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2023-02-13 | 2023-02-14 | 4,527 | $64.55 | $292.2K | 1,173,105 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2023-02-10 | 2023-02-14 | 9,705 | — | $0 | 0 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2023-02-10 | 2023-02-14 | 9,705 | — | $0 | 1,177,632 | SEC↗ |
| EPZM Epizyme, Inc. | D To issuer | 2022-08-12 | 2022-08-16 | 8,994 | — | $0 | 0 | SEC↗ |
| EPZM Epizyme, Inc. | D To issuer | 2022-08-12 | 2022-08-16 | 53,324 | — | $0 | 8,994 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2022-07-01 | 2022-07-06 | 7 | $40.75 | $285 | 1,167,927 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2022-06-30 | 2022-07-05 | 10,204 | $1.47 | $15.0K | 62,318 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2022-05-17 | 2022-05-19 | 41,006 | — | $0 | 41,006 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2022-05-17 | 2022-05-19 | 8,994 | — | $0 | 52,114 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award | 2022-05-02 | 2022-07-06 | 328 | $47.41 | $15.6K | 1,167,934 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2022-03-31 | 2022-04-01 | 13,043 | $1.15 | $15.0K | 43,120 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2022-03-17 | 2022-03-18 | 2,253 | — | $0 | 66,047 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2022-03-17 | 2022-03-18 | 4,612 | — | $0 | 235,388 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2022-03-17 | 2022-03-18 | 229,757 | — | $0 | 0 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2022-03-17 | 2022-03-18 | 229,757 | $5.70 | $1.31M | 1,160,741 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2022-03-17 | 2022-03-18 | 2,253 | $44.37 | $100.0K | 1,167,606 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2022-03-17 | 2022-03-18 | 4,612 | $21.68 | $100.0K | 1,165,353 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2022-03-01 | 2022-03-02 | 14,299 | $76.69 | $1.10M | 930,984 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2022-02-28 | 2022-03-02 | 20,575 | — | $0 | 0 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2022-02-28 | 2022-03-02 | 9,312 | — | $0 | 9,312 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2022-02-28 | 2022-03-02 | 9,312 | — | $0 | 945,283 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2022-02-28 | 2022-03-02 | 20,575 | — | $0 | 935,971 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award deriv | 2022-02-25 | 2022-03-01 | 52,722 | — | $0 | 52,722 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2022-02-24 | 2022-02-25 | 27,126 | $70.10 | $1.90M | 915,396 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2022-02-23 | 2022-02-25 | 58,643 | — | $0 | 0 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2022-02-23 | 2022-02-24 | 5,188 | $69.05 | $358.2K | 883,879 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2022-02-23 | 2022-02-25 | 58,643 | — | $0 | 942,522 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2022-02-22 | 2022-02-24 | 10,373 | — | $0 | 31,122 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2022-02-22 | 2022-02-24 | 10,373 | — | $0 | 889,067 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2022-02-15 | 2022-02-16 | 14,409 | $79.55 | $1.15M | 878,694 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2022-02-14 | 2022-02-16 | 31,133 | — | $0 | 62,265 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2022-02-14 | 2022-02-16 | 96,758 | — | $0 | 0 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2022-02-14 | 2022-02-16 | 94,425 | — | $0 | 0 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2022-02-14 | 2022-02-16 | 31,133 | $78.33 | $2.44M | 893,103 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2022-02-14 | 2022-02-16 | 94,425 | $9.07 | $856.4K | 765,212 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2022-02-14 | 2022-02-16 | 96,758 | $10.82 | $1.05M | 861,970 | SEC↗ |
| ADPT Adaptive Biotechnologies C | A Award deriv | 2022-01-26 | 2022-01-28 | 16,722 | — | $0 | 16,722 | SEC↗ |
| ADPT Adaptive Biotechnologies C | A Award | 2022-01-26 | 2022-01-28 | 6,689 | — | $0 | 8,193 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award | 2022-01-14 | 2022-01-19 | 6,407 | — | $0 | 670,787 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2021-12-31 | 2022-01-04 | 6,000 | $2.50 | $15.0K | 30,077 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2021-11-01 | 2021-11-03 | 16,922 | $93.88 | $1.59M | 664,380 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2021-10-01 | 2021-10-05 | 17,078 | $93.64 | $1.60M | 681,302 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2021-09-30 | 2021-10-01 | 2,930 | $5.12 | $15.0K | 24,077 | SEC↗ |
| SLGCW SomaLogic, Inc. | A Award deriv | 2021-09-01 | 2021-09-03 | 166,666 | — | $0 | 166,666 | SEC↗ |
| SLGCW SomaLogic, Inc. | M Exercise deriv | 2021-09-01 | 2021-09-03 | 25,000 | — | $0 | 0 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2021-09-01 | 2021-09-03 | 18,978 | $104.42 | $1.98M | 698,380 | SEC↗ |
| SLGCW SomaLogic, Inc. | J Other | 2021-09-01 | 2021-09-03 | 25,000 | — | $0 | 25,000 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2021-08-02 | 2021-08-04 | 19,970 | $107.50 | $2.15M | 717,358 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2021-07-01 | 2021-07-06 | 7,784 | $123.43 | $960.8K | 737,328 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2021-06-30 | 2021-07-01 | 1,805 | $8.31 | $15.0K | 21,147 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2021-06-11 | 2021-06-15 | 40,559 | — | $0 | 40,559 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2021-06-11 | 2021-06-15 | 8,060 | — | $0 | 19,342 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2021-06-01 | 2021-06-03 | 12,384 | $111.00 | $1.37M | 745,112 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2021-05-03 | 2021-05-05 | 19,240 | $131.09 | $2.52M | 757,496 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award | 2021-04-30 | 2021-05-05 | 328 | $64.74 | $21.2K | 776,736 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2021-04-01 | 2021-04-05 | 22,755 | $132.30 | $3.01M | 776,408 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2021-03-31 | 2021-04-01 | 1,723 | $8.71 | $15.0K | 11,282 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2021-03-02 | 2021-03-03 | 9,796 | $138.42 | $1.36M | 799,163 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2021-03-01 | 2021-03-03 | 20,575 | — | $0 | 20,575 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2021-03-01 | 2021-03-02 | 26,958 | $136.79 | $3.69M | 788,384 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2021-03-01 | 2021-03-02 | 4,335 | $137.44 | $595.8K | 815,342 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2021-03-01 | 2021-03-03 | 20,575 | — | $0 | 808,959 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2021-02-26 | 2021-03-02 | 9,312 | — | $0 | 18,624 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2021-02-26 | 2021-03-02 | 9,312 | — | $0 | 819,677 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2021-02-24 | 2021-02-25 | 16,420 | $136.30 | $2.24M | 810,365 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2021-02-23 | 2021-02-25 | 34,325 | — | $0 | 0 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2021-02-23 | 2021-02-25 | 34,325 | — | $0 | 826,785 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award deriv | 2021-02-19 | 2021-02-23 | 41,495 | — | $0 | 41,495 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2021-02-17 | 2021-02-18 | 15,825 | $142.66 | $2.26M | 792,460 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2021-02-16 | 2021-02-18 | 31,132 | — | $0 | 93,398 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2021-02-16 | 2021-02-18 | 31,132 | — | $0 | 808,285 | SEC↗ |
| ADPT Adaptive Biotechnologies C | A Award deriv | 2021-02-14 | 2021-02-17 | 3,759 | — | $0 | 3,759 | SEC↗ |
| ADPT Adaptive Biotechnologies C | A Award | 2021-02-14 | 2021-02-17 | 1,504 | — | $0 | 1,504 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2021-02-05 | 2021-02-09 | 17,543 | — | $0 | 229,757 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2021-02-05 | 2021-02-09 | 17,543 | $5.70 | $100.0K | 777,153 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2021-02-01 | 2021-02-03 | 30,344 | $138.07 | $4.19M | 759,610 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2021-01-04 | 2021-01-07 | 31,814 | $128.74 | $4.10M | 825,704 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2020-12-31 | 2021-01-05 | 1,024 | $10.86 | $11.1K | 9,559 | SEC↗ |
| EXAS EXACT SCIENCES CORP | G Gift | 2020-12-28 | 2021-02-03 | 35,750 | — | $0 | 789,954 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2020-12-01 | 2020-12-02 | 100 | $126.59 | $12.7K | 857,518 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2020-12-01 | 2020-12-02 | 2,918 | $122.91 | $358.7K | 883,377 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2020-12-01 | 2020-12-02 | 1,800 | $122.05 | $219.7K | 886,295 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2020-12-01 | 2020-12-02 | 7,776 | $124.03 | $964.5K | 875,601 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2020-12-01 | 2020-12-02 | 100 | $126.49 | $12.6K | 857,618 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2020-12-01 | 2020-12-02 | 7,043 | $125.92 | $886.9K | 857,718 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2020-12-01 | 2020-12-02 | 10,840 | $124.88 | $1.35M | 864,761 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2020-11-02 | 2020-11-03 | 9,577 | $122.33 | $1.17M | 889,095 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2020-11-02 | 2020-11-03 | 10,229 | $121.52 | $1.24M | 898,672 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2020-11-02 | 2020-11-03 | 6,512 | $120.45 | $784.4K | 908,901 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2020-11-02 | 2020-11-03 | 4,393 | $118.32 | $519.8K | 916,521 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2020-11-02 | 2020-11-03 | 400 | $124.71 | $49.9K | 888,095 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2020-11-02 | 2020-11-03 | 600 | $123.45 | $74.1K | 888,495 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2020-11-02 | 2020-11-03 | 1,108 | $119.18 | $132.1K | 915,413 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2020-10-01 | 2020-10-02 | 1,136 | $105.20 | $119.5K | 920,914 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2020-10-01 | 2020-10-02 | 5,200 | $104.70 | $544.4K | 922,050 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2020-10-01 | 2020-10-02 | 11,698 | $102.86 | $1.20M | 936,641 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2020-10-01 | 2020-10-02 | 9,391 | $103.57 | $972.6K | 927,250 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2020-09-30 | 2020-10-01 | 933 | $11.93 | $11.1K | 8,535 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2020-09-01 | 2020-09-02 | 19,927 | $75.03 | $1.50M | 948,339 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2020-08-03 | 2020-08-04 | 198 | $95.00 | $18.8K | 968,266 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2020-08-03 | 2020-08-04 | 25,000 | $93.79 | $2.34M | 968,464 | SEC↗ |
| ARYA ARYA SCIENCES ACQUISITION | D To issuer deriv | 2020-07-01 | 2020-07-06 | 30,000 | — | $0 | 0 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2020-06-30 | 2020-07-01 | 693 | $16.06 | $11.1K | 7,602 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2020-05-29 | 2020-06-02 | 14,013 | — | $0 | 14,013 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award | 2020-04-30 | 2020-08-04 | 501 | $42.44 | $21.3K | 993,464 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2020-03-31 | 2020-04-02 | 717 | $15.51 | $11.1K | 6,909 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2020-02-28 | 2020-03-02 | 9,750 | $80.17 | $781.7K | 992,963 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2020-02-27 | 2020-03-02 | 20,575 | — | $0 | 41,150 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2020-02-27 | 2020-02-28 | 13,875 | $80.27 | $1.11M | 982,138 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2020-02-27 | 2020-03-02 | 20,575 | — | $0 | 1,002,713 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2020-02-26 | 2020-02-28 | 20,025 | — | $0 | 0 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2020-02-26 | 2020-02-28 | 9,312 | — | $0 | 27,936 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2020-02-26 | 2020-02-28 | 20,025 | — | $0 | 986,701 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2020-02-26 | 2020-02-28 | 9,312 | — | $0 | 996,013 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2020-02-25 | 2020-02-26 | 18,115 | $85.11 | $1.54M | 966,676 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2020-02-24 | 2020-02-26 | 34,325 | — | $0 | 34,325 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2020-02-24 | 2020-02-26 | 34,325 | — | $0 | 984,791 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award deriv | 2020-02-14 | 2020-02-18 | 124,530 | — | $0 | 124,530 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award deriv | 2020-02-14 | 2020-02-18 | 100,916 | — | $0 | 100,916 | SEC↗ |
| ADPT Adaptive Biotechnologies C | A Award deriv | 2020-02-13 | 2020-02-18 | 8,888 | — | $0 | 8,888 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2019-12-31 | 2020-01-03 | 452 | $24.60 | $11.1K | 6,192 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2019-12-16 | 2019-12-18 | 4,277 | — | $0 | 66,723 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2019-12-16 | 2019-12-18 | 7,163 | — | $0 | 102,837 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2019-12-16 | 2019-12-18 | 7,163 | $13.96 | $100.0K | 946,189 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2019-12-16 | 2019-12-18 | 4,277 | $23.38 | $100.0K | 950,466 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2019-09-30 | 2019-10-02 | 1,078 | $10.32 | $11.1K | 5,740 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2019-06-30 | 2019-07-02 | 887 | $12.55 | $11.1K | 4,662 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2019-05-31 | 2019-06-07 | 17,633 | — | $0 | 17,633 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award | 2019-04-30 | 2019-12-18 | 500 | $42.44 | $21.2K | 939,026 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2019-03-31 | 2019-06-07 | 897 | $12.39 | $11.1K | 3,775 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2019-03-11 | 2019-03-12 | 11,227 | $87.21 | $979.1K | 938,526 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2019-03-09 | 2019-03-12 | 24,400 | — | $0 | 0 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2019-03-09 | 2019-03-12 | 24,400 | — | $0 | 949,753 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2019-02-28 | 2019-03-01 | 10,014 | $93.20 | $933.3K | 925,353 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2019-02-27 | 2019-02-28 | 20,575 | — | $0 | 61,725 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2019-02-27 | 2019-02-28 | 9,169 | $95.07 | $871.7K | 914,792 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2019-02-27 | 2019-02-28 | 20,575 | — | $0 | 935,367 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2019-02-26 | 2019-02-28 | 20,025 | — | $0 | 20,025 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award deriv | 2019-02-26 | 2019-02-28 | 34,110 | — | $0 | 34,110 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award deriv | 2019-02-26 | 2019-02-28 | 37,248 | — | $0 | 37,248 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2019-02-26 | 2019-02-28 | 20,025 | — | $0 | 923,961 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2019-02-25 | 2019-02-26 | 16,400 | $90.55 | $1.49M | 903,936 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2019-02-23 | 2019-02-26 | 34,325 | — | $0 | 68,650 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2019-02-23 | 2019-02-26 | 34,325 | — | $0 | 920,336 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2019-01-25 | 2019-01-25 | 23,236 | $82.49 | $1.92M | 886,011 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2019-01-25 | 2019-01-25 | 181,250 | $81.90 | $14.84M | 909,247 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2019-01-25 | 2019-01-25 | 36,453 | $80.78 | $2.94M | 1,090,497 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2019-01-25 | 2019-01-25 | 28,605 | $79.89 | $2.29M | 1,126,950 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2019-01-25 | 2019-01-25 | 34,853 | $78.80 | $2.75M | 1,155,555 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2019-01-24 | 2019-01-25 | 304,397 | — | $0 | 0 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2019-01-24 | 2019-01-25 | 304,397 | — | $0 | 1,190,408 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award deriv | 2019-01-02 | 2019-01-04 | 304,397 | — | $0 | 304,397 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2018-11-12 | 2018-11-14 | 163,514 | — | $0 | 0 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2018-11-12 | 2018-11-14 | 163,514 | $69.00 | $11.28M | 886,011 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2018-11-12 | 2018-11-14 | 163,514 | $0.83 | $135.7K | 1,049,525 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2018-07-02 | 2018-07-02 | 2,878 | $13.55 | $39.0K | 2,878 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2018-05-18 | 2018-05-31 | 12,500 | — | $0 | 12,500 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award | 2018-04-30 | 2018-11-14 | 3,572 | $5.95 | $21.3K | 886,011 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2018-03-12 | 2018-03-13 | 11,459 | $52.19 | $598.0K | 882,439 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2018-03-09 | 2018-03-13 | 24,400 | — | $0 | 24,400 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2018-03-09 | 2018-03-13 | 24,400 | — | $0 | 893,898 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award deriv | 2018-02-27 | 2018-02-28 | 68,300 | — | $0 | 68,300 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award deriv | 2018-02-27 | 2018-02-28 | 82,300 | — | $0 | 82,300 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2018-02-27 | 2018-02-28 | 9,085 | $44.10 | $400.6K | 869,498 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2018-02-26 | 2018-02-28 | 20,025 | — | $0 | 40,050 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2018-02-26 | 2018-02-27 | 25,319 | $42.34 | $1.07M | 858,558 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2018-02-26 | 2018-02-28 | 20,025 | — | $0 | 878,583 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2018-02-24 | 2018-02-27 | 19,500 | — | $0 | 0 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2018-02-24 | 2018-02-27 | 19,500 | — | $0 | 883,877 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2018-02-23 | 2018-02-27 | 34,325 | — | $0 | 102,975 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2018-02-23 | 2018-02-27 | 34,325 | — | $0 | 864,377 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2018-02-09 | 2018-02-13 | 101,488 | — | $0 | 163,514 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2018-02-09 | 2018-02-13 | 41,526 | $44.60 | $1.85M | 890,014 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2018-02-09 | 2018-02-13 | 50,504 | $46.54 | $2.35M | 839,510 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2018-02-09 | 2018-02-13 | 9,458 | $46.29 | $437.8K | 830,052 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2018-02-09 | 2018-02-13 | 101,488 | $0.83 | $84.2K | 931,540 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2018-01-23 | 2018-01-25 | 110,439 | — | $0 | 265,002 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2018-01-23 | 2018-01-25 | 12,077 | $48.87 | $590.2K | 928,414 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2018-01-23 | 2018-01-25 | 41,588 | $50.72 | $2.11M | 860,088 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2018-01-23 | 2018-01-25 | 110,439 | $0.83 | $91.7K | 940,491 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2018-01-23 | 2018-01-25 | 30,036 | $51.66 | $1.55M | 830,052 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2018-01-23 | 2018-01-25 | 26,738 | $49.54 | $1.32M | 901,676 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2018-01-12 | 2018-01-17 | 125,402 | — | $0 | 375,441 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2018-01-12 | 2018-01-17 | 25,912 | $53.24 | $1.38M | 830,052 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2018-01-12 | 2018-01-17 | 125,402 | $0.83 | $104.1K | 955,454 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2018-01-12 | 2018-01-17 | 99,490 | $52.68 | $5.24M | 855,964 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2017-12-22 | 2017-12-26 | 123,512 | — | $0 | 500,843 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2017-12-22 | 2017-12-26 | 27,065 | $53.36 | $1.44M | 830,052 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2017-12-22 | 2017-12-26 | 96,447 | $52.37 | $5.05M | 857,117 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2017-12-22 | 2017-12-26 | 123,512 | $0.83 | $102.5K | 953,564 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2017-12-06 | 2017-12-08 | 121,849 | — | $0 | 624,355 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2017-12-06 | 2017-12-08 | 28,370 | $53.81 | $1.53M | 830,052 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2017-12-06 | 2017-12-08 | 93,479 | $53.35 | $4.99M | 858,422 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2017-12-06 | 2017-12-08 | 121,849 | $0.83 | $101.1K | 951,901 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2017-11-21 | 2017-11-22 | 134,057 | — | $0 | 746,204 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2017-11-21 | 2017-11-22 | 134,057 | $59.50 | $7.98M | 830,052 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2017-11-21 | 2017-11-22 | 134,057 | $0.83 | $111.3K | 964,109 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2017-11-09 | 2017-11-13 | 137,815 | — | $0 | 880,261 | SEC↗ |